Target Price | $5.10 |
Price | $4.13 |
Potential |
23.49%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Medical Properties Trust 2026 .
The average Medical Properties Trust target price is $5.10.
This is
23.49%
register free of charge
$7.35
77.97%
register free of charge
$3.54
14.41%
register free of charge
|
|
A rating was issued by 18 analysts: 2 Analysts recommend Medical Properties Trust to buy, 7 to hold and 9 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Medical Properties Trust stock has an average upside potential 2026 of
23.49%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 995.55 | 952.61 |
14.19% | 4.31% | |
EBITDA Margin | 83.82% | 84.80% |
6.74% | 1.17% | |
Net Margin | -242.20% | -2.80% |
278.32% | 98.84% |
10 Analysts have issued a sales forecast Medical Properties Trust 2025 . The average Medical Properties Trust sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Medical Properties Trust EBITDA forecast 2025. The average Medical Properties Trust EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Medical Properties Trust Analysts have issued a net profit forecast 2025. The average Medical Properties Trust net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -4.02 | -0.04 |
332.26% | 99.00% | |
P/E | negative | |
EV/Sales | 11.86 |
7 Analysts have issued a Medical Properties Trust forecast for earnings per share. The average Medical Properties Trust EPS is
This results in the following potential growth metrics and future valuations:
Medical Properties Trust...
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
Exane BNP Paribas |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
Mizuho |
Locked
➜
Locked
|
Locked | Dec 05 2024 |
Colliers Securities |
Locked
➜
Locked
|
Locked | Sep 13 2024 |
Analyst Rating | Date |
---|---|
Locked
RBC Capital:
Locked
➜
Locked
|
Jun 30 2025 |
Locked
Exane BNP Paribas:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Mar 10 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Mar 10 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Dec 19 2024 |
Locked
Mizuho:
Locked
➜
Locked
|
Dec 05 2024 |
Locked
Colliers Securities:
Locked
➜
Locked
|
Sep 13 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.